Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842 | VSV-EBOVAC | Project | Results | H2020 | CORDIS

Rezultaty

Distribution of intermediate samples (day 28) to partners involved in immunogenicity studies

Migration

Predictive correlates of protective immunity and safety determined.

Migration

Establishment of the External Advisory Board

Migration

Distribution of late samples (> day 28) to partners involved in immunogenicity studies

Migration

Distribution of early samples (day 0-14) to partners involved in immunogenicity studies

Migration

Web site development and maintenance

Migration

Publikacje

Ebola vaccine R&D: Filling the knowledge gaps

Autorzy: Donata Medaglini, Ali M. Harandi, Tom H. M. Ottenhoff, Claire-Anne Siegrist, VSV-EBOVAC Consortium
Opublikowane w: Science Translational Medicine, Numer 7/317, 2015, Strona(/y) 317ps24-317ps24, ISSN 1946-6234
Wydawca: American Association for the Advancement of Science
DOI: 10.1126/scitranslmed.aad3106

Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine

Autorzy: Donata Medaglini, Claire-Anne Siegrist
Opublikowane w: Current Opinion in Virology, Numer 23, 2017, Strona(/y) 88-94, ISSN 1879-6257
Wydawca: Elsevier BV
DOI: 10.1016/j.coviro.2017.03.008

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Autorzy: Angela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, José F Fernandes, Emmanuel Bache Bache, Lumeka Kabwende, Francis Maina Ndungu, Jessica Brosnahan, Thomas P Monath, Barbara Lemaître, Stéphane Grillet, Miriam Botto, Olivier Engler, Jasmine Portmann, Denise Siegrist, Philip Bejon, Peter Silvera, Peter Kremsner, Claire-Anne Siegrist, Sanjeev KRISHNA, Marylyn M. ADDO, Stephan BECKER,
Opublikowane w: The Lancet Infectious Diseases, Numer 18/7, 2018, Strona(/y) 738-748, ISSN 1473-3099
Wydawca: The Lancet Publishing Group
DOI: 10.1016/S1473-3099(18)30165-8

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa

Autorzy: Angela Huttner, Christophe Combescure, Stéphane Grillet, Mariëlle C. Haks, Edwin Quinten, Christine Modoux, Selidji Todagbe Agnandji, Jessica Brosnahan, Julie-Anne Dayer, Ali M. Harandi, Laurent Kaiser, Donata Medaglini, Tom Monath, Pascale Roux-Lombard, Peter G. Kremsner, Tom H. M. Ottenhoff, Claire-Anne Siegrist
Opublikowane w: Science Translational Medicine, Numer 9/385, 2017, Strona(/y) eaaj1701, ISSN 1946-6234
Wydawca: American Association for the Advancement of Science
DOI: 10.1126/scitranslmed.aaj1701

Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?

Autorzy: Angela Huttner, Claire-Anne Siegrist
Opublikowane w: Expert Review of Vaccines, Numer 17/12, 2018, Strona(/y) 1105-1110, ISSN 1476-0584
Wydawca: Future Drugs Ltd.
DOI: 10.1080/14760584.2018.1546582

Correlates of vaccine-induced protective immunity against Ebola virus disease

Autorzy: Donata Medaglini, Francesco Santoro, Claire-Anne Siegrist
Opublikowane w: Seminars in Immunology, Numer 39, 2018, Strona(/y) 65-72, ISSN 1044-5323
Wydawca: Academic Press
DOI: 10.1016/j.smim.2018.07.003

Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842

Rezultaty

Publikacje

Udostępnij tę stronę

Pobierz